Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Pharmacist's Guide to Managing Anemia in Chronic Kidney Disease


Description:
This is a FREE activity
To educate participants on the treatment recommendations and goals for patients with anemia and chronic kidney disease.  The session will begin with an overview of chronic kidney disease including delineation of stages, epidemiology, and complications.  Particular focus will be on anemia in CKD – its causes, symptoms, diagnosis and treatment.  The guidelines for managing anemia in CKD and available medications will be covered in detail.  The discussion of treatment options will outline dosing, administration routes, warnings and contraindications, potential adverse effects, and monitoring.  Participants will have an opportunity to review patient cases and select the appropriate treatment strategy for each.  

Objectives:

  1. Explain the impact of anemia on quality of life and mortality risk.
  2. Compare and contrast therapies used in the management of anemia in patients with CKD.
  3. Discuss laboratory tests and monitoring parameters used to evaluate anemia.
  4. Identify a treatment plan for management of anemia based on patient specific factors.
Activity Number:
0280-0000-17-096-H01-P

This recorded activity is a based on a live program that was offered on May 16, 2017 in Cromwell, CT.  
Participants who received credit for the live program should not claim credit for this web based presentation.
 
System Requirements for Participants:
Operating system:  Windows XP, Vista or 7  MAC OS X  Latest Version of Adobe Reader
Browser Internet Explorer 8.0 or above  Google Chrome 16.0 or above  Firefox 7.0 or above  Safari 5.0 or above
 

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
American Health Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

Requirements for CE Credit

  • Complete the pre-test
  • Review the content of this activity
  • Successfully complete the post-test with a score of 80% or higher 
  • Complete the evaluation
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation is completed.
 
Pharmacists - Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits will NOT be reported.

Support/Credits

Disclosures:
The presenter is Indu Lew, PharmD; Vice President, Corporate Pharmacy-Clinical Pharmacy Services, RWJBarnabas Health, West Orange, NJ 
Dr. Lew  is on the speaker’s bureaus for American Regent and Amgen; presenter is also on the Advisory board of Novartis.     
 
The reviewer is Darren Grabe, PharmD; Associate Professor of Pharmacy Practice, Albany College of Pharmacy; Adjunct Assistant Professor, Albany Medical College; Albany Nephrology Pharmacy Group, Albany, NY.
Dr. Grabe does not have any relevant financial relationships with any commercial interests.
 
Support for This Activity:
Educational grant funding was received from American Regent
 
American Health Resources assesses conflict of interest with its instructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity.
 
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  American Health Resources does not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

 

 

This is a FREE activity
To educate participants on the treatment recommendations and goals for patients with anemia and chronic kidney disease.  The session will begin with an overview of chronic kidney disease including delineation of stages, epidemiology, and complications.  Particular focus will be on anemia in CKD – its causes, symptoms, diagnosis and treatment.  The guidelines for managing anemia in CKD and available medications will be covered in detail.  The discussion of treatment options will outline dosing, administration routes, warnings and contraindications, potential adverse effects, and monitoring.  Participants will have an opportunity to review patient cases and select the appropriate treatment strategy for each.  
Knowledge Based

Objectives

  • Explain the impact of anemia on quality of life and mortality risk.
  • Compare and contrast therapies used in the management of anemia in patients with CKD.
  • Discuss laboratory tests and monitoring parameters used to evaluate anemia.
  • Identify a treatment plan for management of anemia based on patient specific factors.

Speaker(s)/Author(s)

Indu Lew, PharmD picture

Indu Lew, PharmD
Vice President, RWJ Barnabas Health


Brief Bio : Vice President Corporate Pharmacy-Clinical Pharmacy Services, RWJBarnabas Health, South Plainfield, NJ

Activity Number

0280-0000-17-096-H01-P

Release Date: Aug 21, 2017
Credit Expiration Date: Aug 21, 2020

CE Hours

1.00

Fee

$0.00